Food News and Research

RSS

AMRI reports $50.2 million total revenue for third quarter 2011

...

9 Nov 2011

Boston Scientific reports positive long-term data from PERSEUS clinical program

Boston Scientific Corporation reports positive long-term data from the PERSEUS clinical program, which demonstrated favorable two-year safety and effectiveness outcomes for the ION (TAXUS Element) Paclitaxel-Eluting Platinum Chromium Stent System versus prior-generation paclitaxel-eluting stents.

9 Nov 2011

RNS system offers significant relief to patients with intractable seizures

Brain stimulation, already approved by the U.S. Food and Drug Administration for the treatment of Parkinson's disease and essential tremor, has now been shown to offer significant relief to patients with intractable seizures for whom drugs and other treatments have not worked.

9 Nov 2011

State roundup: Kansas Medicaid announcement; pilot projects for nursing homes, C-sections; Calif. marijuana clinics

Gov. Sam Brownback, Lt. Gov. Jeff Colyer and three Cabinet officials have scheduled a news conference for 10 a.m. Tuesday to describe details of their plan for making over the Kansas Medicaid program. ... The plan is expected to include a significant expansion of managed care.

9 Nov 2011

Bioject third quarter revenues increase to $3.1 million

Bioject Medical Technologies Inc., a leading developer of needle-free drug delivery systems, today reported financial results for the third quarter ended September 30, 2011.

8 Nov 2011

FDA grants Fast Track designation to Opexa's Tovaxin for treatment of SPMS

Opexa Therapeutics, Inc., announced today that its lead drug candidate Tovaxin® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Secondary Progressive Multiple Sclerosis.

8 Nov 2011

First Edition: November 8, 2011

Today's early morning highlights from the major news organizations, including stories on malpractice reforms and previews of voting in Ohio on two ballot questions affecting health care issues and a Mississippi abortion issue.

8 Nov 2011

Cigarette package warnings stopped citing free speech

A federal judge has obstructed a U.S. rule requiring tobacco companies to display graphic images on cigarette packs citing free speech.

8 Nov 2011

Medics fail to give patients crucial information about link between obesity and cancer

People who work in health care are failing to give patients crucial information about the link between obesity and cancer according to new research presented today at the National Cancer Research Institute Cancer Conference (NCRI) in Liverpool.

8 Nov 2011

QRxPharma receives date for US pain drug launch, pending approval

Australian pain-relief drug developer QRxPharma (QRX) has announced today that they have received from the US Food & Drug Adminstration.

8 Nov 2011

ACR honors NYU Langone professor with Distinguished Basic Investigator Award

Steven B. Abramson, MD, senior vice president and vice dean of education, faculty and academic affairs and professor, Departments of Medicine and Pathology at NYU Langone Medical Center received the Distinguished Basic Investigator Award at the American College of Rheumatology (ACR) & Association of Rheumatology Health Professionals (ARHP) annual scientific meeting this week in Chicago.

8 Nov 2011

Suggestions for making a difference in fighting hunger, food shortages

Kristi York Wooten, founder of SustenanceGroup.org and an advocate for fighting hunger and poverty, "canvassed a panel of colleagues and experts for thoughts on how corporations and governments and the rest of us can make a difference to ensure a sustainable future," and presents her findings in this post on the Huffington Post's "Impact" blog.

8 Nov 2011

South Korea considering food assistance for North Korea, official says

"Signaling South Korea may be attempting to cool tensions with its neighbor, Seoul has vowed to actively review sending humanitarian aid to North Korea through third channels," CNN reports.

8 Nov 2011

Congress examines options to improve availability of prescription drugs

Shortages of prescription drugs are leaving a growing number of patients waiting for life-saving medicines. Federal officials say the number of prescriptions in short supply tripled from 2005 to 2010. Limited supplies of some drugs have sent prices soaring 1,000 times above normal.

8 Nov 2011

U.N. increasing joint aid efforts with Cambodian government to assist flood victims

The U.N. reported Friday "that it is increasing its joint efforts with Cambodian authorities and aid providers to offer food assistance to some of the thousands of people that have been displaced by severe flooding recently," the U.N. News Centre reports.

8 Nov 2011

EpiCept reports net loss of $5.4 million for third quarter 2011

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.

8 Nov 2011

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

8 Nov 2011

DSM and Svelte Medical Systems enter into license and supply agreement

DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM’s proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.

7 Nov 2011

Neogen's new Soleris test detects yeast and mold in 48 hours

Neogen Corporation has developed an even quicker method to rapidly and accurately detect yeast and mold in food products. Neogen's new Soleris® test detects yeast and mold in 48 hours or less — conventional methods take up to 5 days.

7 Nov 2011

ACADIA and Meiji Seika collaborate to develop AM-831 for schizophrenia treatment

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.

7 Nov 2011